Clinical characteristics of autoantibodies neutralizing type I interferons in patients with coronavirus disease 2019 across phases of severe acute respiratory syndrome coronavirus 2 circulation
{{output}}
Background: Autoantibodies neutralizing type I interferons (AAN-I-IFNs) have been identified as major risk factors for life-threatening coronavirus disease 2019 (COVID-19), particularly during the early phase of severe acute resp... ...
